Culturas
Kylie Minogue, Pulp, Kiwanuka y Bad Gyal en el Bilbao BBK Live 2025
2024-12-04
La cantante australiana Kylie Minogue se prepara para abrir el cartel del Festival Bilbao BBK Live, un evento que atraerá a una amplia variedad de artistas. Este festival se celebrará los días 10, 11 y 12 de julio y promete ofrecer una experiencia musical inolvidable.

Descubre la magia musical del Festival Bilbao BBK Live

Presentación de Kylie Minogue

Kylie Minogue, figura del pop global, interpretará sobre el escenario del BBK Live las canciones de su último disco, Tension II. Con éxitos como Padam Padam, ella mostrará su talento y marcará un hito en el festival. Sus tres décadas de trayectoria la han convertido en una icónica en el mundo del pop.

Además de sus propios éxitos, Kylie Minogue traerá un aura especial a la fiesta. Su presencia atraerá a un público entusiasta y hará que el festival sea un evento inolvidable.

Artistas confirmados

Junto a Kylie Minogue, el festival cuenta con una amplia gama de artistas. La banda británica de Britpop Pulp, el intérprete de soul y folk Michael Kiwanuka y la música urbana de Bad Gyal también forman parte del cartel. Estos artistas aportarán su estilo único y diversidad musical al evento.

Además, la argentina Nathy Pelusso, ganadora de tres Latin Gammy, y la británica Raye, con su álbum My 21st Century Blues y su fusión de R&B, soul y dance, se unirán al festival. Estos artistas representan diferentes géneros y culturas musicales, lo que hará que el festival sea una experiencia multicultural.

Artistas electrónicos

El festival también cuenta con tres pilares de la música electrónica. Orbital, pioneros en los 90 por redefinir el directo con su fusión de géneros, Bicep con su nuevo show Chroma y The Blessed Madonna con su sonido house, aportarán un toque electrónico y moderno al festival.

Además de estos artistas, el cartel se completará con artistas como Japanese Breakfast, Amaia, L’Impératrice, Polo & Pan, Ca7riel y Paco Amoroso, Amyl and The Sniffers, Carolina Durante, Rusowsky y Judeline. Cada uno de estos artistas traerá su estilo y energía musical al festival, haciendo que sea un evento lleno de sorpresas.

Kennesaw State's HOPE Lab Transforms Healthcare with Tech
2024-12-04
Researchers at Kennesaw State University's HOPE Lab are on a mission to transform healthcare. In December 2024, they are integrating eye-tracking sensors and wearable exoskeletons to address key issues. By doing so, they aim to enhance patient safety, cut costs, and boost care quality. This blend of industrial engineering and healthcare insights is redefining healthcare processes.

Revolutionizing Healthcare with Advanced Tech

Improving Patient Safety

Outdated healthcare workflows often lead to inefficiencies and unnecessary strain. In the HOPE Lab, sensors are used to identify constraints and eliminate redundant steps. This not only improves staff performance but also directly impacts patient care. As Awatef Ergai emphasizes, outdated processes drive up costs and put pressure on both patients and providers. By refining these workflows, healthcare becomes more affordable, safe, and effective.

For example, eye-tracking sensors monitor healthcare workers' attention, revealing areas of potential distraction. Analyzing this data allows the team to suggest changes to workflow layouts and training protocols, enhancing concentration and reducing errors. In high-stress environments like emergency rooms, this real-time monitoring is crucial for quick decision-making and clear focus.

Reducing Costs and Burnout

Healthcare costs are on the rise, and healthcare workers often face burnout due to long hours and high-stress environments. The HOPE Lab's research focuses on addressing these issues. Wearable exoskeletons and motion capture sensors play a vital role in improving physical ergonomics.

These devices support healthcare workers by reducing the physical toll of repetitive tasks. By tracking movements and monitoring muscle and joint stress, exoskeletons provide real-time assistance, redistributing weight and preventing musculoskeletal injuries. This leads to fewer absences and turnovers due to injury, allowing workers to perform their duties more sustainably.

Interdisciplinary Collaboration

The lab's success depends on interdisciplinary collaboration. By partnering with Wellstar Health System, the Coles College of Business, and various colleges within the university, they gain valuable insights and test their designs in real-world clinical settings.

Collaborating with Doreen Wagner, Mark Geil, Katherine Ingram, Sweta Sneha, Adriane Randolph, Maria Valero, Yong Shi, Paola Spoletini, and Israel Sanchez-Cardona, they ensure that their solutions are technologically sound and closely aligned with real-world healthcare needs. This collaborative approach strengthens their research and leads to more effective outcomes.

As the healthcare industry evolves, KSU researchers envision a future where human-centered design and advanced technology are seamlessly integrated. They strive to create a system where technology works for the people, not the other way around.

See More
GE HealthCare Submits Deep Learning Tech for FDA Approval at RSNA
2024-12-04
At this year's RSNA meeting in Chicago, US, GE HealthCare made a significant announcement. They have submitted a 510(k) application to the US Food and Drug Administration (FDA) for CleaRecon DL, a deep learning technology that utilizes AI-based 3D reconstruction to enhance the quality of cone-beam computed tomography (CBCT) images.

Improving Image Quality and Clinical Confidence

The technology will be available for GE HealthCare's Allia image-guided solutions (IGS) systems. It removes streaks, heightening clinicians' confidence in image interpretation when analyzing CBCT data. For instance, the Allia IGS Pulse system, aimed at enhancing workflow in diagnosing and treating cardiovascular diseases in interventional cardiology, received FDA clearance in October 2023. Arnaud Marie, general manager for global intervention at GE HealthCare, emphasized the significance of this technology. He stated that over the years, artifacts created during scans due to the natural movement of the body and the distribution of contrast have posed a major challenge to clinicians when obtaining CBCT images, acting as a significant barrier to the adoption of CBCT technology. CleaRecon DL is designed to address this issue, enabling physicians and their patients to benefit from advanced imaging technology.

GE HealthCare's Range of Technologies

In addition to CleaRecon DL, GE HealthCare also launched Sonic DL, another deep learning technology. This technology is designed to expedite magnetic resonance imaging (MRI) scans across various clinical applications. This week, the medtech giant entered an agreement to purchase the remaining 50% stake in Nihon Medi-Physics (NMP) from Sumitomo Chemical, having held 50% in NMP since acquiring Amersham in 2004.

RSNA News and Other Highlights

During the Radiological Society of North America's (RSNA) 2024 meeting, GE HealthCare provided an update on the FDA submission. Philips showcased its next-generation BlueSeal 1.5T magnetic resonance imaging system at the meeting. US-based radiology practice Radiology Partners (RP) announced a partnership with RADPAIR to further the development of generative AI use in radiology. According to GlobalData’s Market Size & Growth database, the global diagnostic imaging space was valued at around $36.3bn in 2023 and is forecast to reach a valuation of around $54.8bn by 2033.
See More